Moreadith Randall W 4
4 · NEKTAR THERAPEUTICS · Filed Feb 25, 2009
Insider Transaction Report
Form 4
Moreadith Randall W
SVP Drug Development
Transactions
- Award
Employee Stock Option
2009-02-23$4.65/sh+85,000$395,250→ 85,000 totalExercise: $4.65Exp: 2017-02-23→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]Annual equity grant.
- [F2]The shares subject to the employee stock option vest on a monthly pro-rata basis over four years with all of such shares vesting on February 23, 2013.